Wouter Meuleman

Wouter Meuleman is a Life Science Investor and Partner at Illumina Ventures, where they focus on early-stage investments in genomics and nucleic acid sequencing innovations. They hold multiple board positions at companies such as Fluent BioSciences Inc., RedShiftBio, and Biota Technology, contributing to advancements in molecular analytics and DNA sequencing. Wouter previously served as a Project Leader at Oxford Gene Technology and held various scientific roles in the biopharmaceutical sector. They earned a PhD from Newcastle University and an MBA from the University of Cambridge.